| 2.27 Data as of 3:16pm ET |  +0.015 / +0.67%Today’s Change | 1.33 Today|||52-Week Range 3.16 | -16.11% Year-to-Date |
| Interesting ENZ Call For January 2014 May 20 / TheStreet.com |
| Previous close | 2.25 |
| Today’s open | 2.24 |
| Day’s range | 2.19 - 2.27 |
| Volume | 35,359 |
| Average volume (3 months) | 102,583 |
| Market cap | $106.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -197.06% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1.03% |
| P/E ratio | NM |
| Price/Sales | 0.56 |
| Price/Book | 1.80 |
| Today’s change | Today’s % change | |
|---|---|---|
| BSTCBiospecifics Technol... | +0.06 | +0.38% |
| ONTYOncothyreon Inc | -0.00 | -0.25% |
| CDXSCodexis Inc | +0.03 | +1.48% |
| PBMDPrima BioMed Ltd | 0.00 | 0.00% |
| Last reporting date | June 12, 2012 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $103.1M |
| Annual profit (last year) | -$39.3M |
| Net profit margin | -38.09% |
Sector Health Technology |
Industry Biotechnology |
Chairman, Chief Executive Officer & Secretary Elazar Rabbani, PhD |
President, CFO, Treasurer, Director & CAO Barry W. Weiner, MBA |
Corporate headquarters New York, New York |
.
